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Intercellular adhesion molecule-1 (ICAM-1) functions as a 
ligand of leukocyte function- associated antigen-1 {LFA-1 ), 
as well as a receptor for human picornavirus, and its regula-
tion thus affects various immunologic and inflammatory re-
actions. The weak, constitutive ICAM-1 expression on 
human keratinocytes {KC) can be up-regulated by cytokines 
such as interferon-gamma (IFNy) and tumor necrosis factor 
alpha (TNFa). In order to further examine the regulation of 
KC ICAM-1 ex,Pression, normal human KC or epidermoid 
carcinoma cells (KB) were incubated with different cytokines 
and/or exposed to ultraviolet {UV) radiation. Subsequently, 
ICAM-1 expression was monitored cytofluorometrically 
using a monoclonal anti-ICAM-1 antibody. Stimulation of 
cells with recombinant human (rh) interleukin (IL) 1a, 
rhiL-4, rhiL-5, rhiL-6, rh granulocyte/macrophage colony-
stimulating factor (GM-CSF), rh interferon alpha (rhiFNa), 
A dhesion molecules are newly recognized cell-surface receptors that play an important role in various immu-nologic and inflammatory reactions by mediating lymphocyte - target-cell and lymphocyte- accessory-cell communication (1,2]. Adhesion may occur either 
by binding of lymphocyte CD2 antigen to target-cell lymphocyte 
function- associated antigen (LFA)-3 molecules or via interaction 
of lymphocyte LFA-1 with target-cell intercellular adhesion mole-
cule-1 (ICAM-1) (3). In the human epidermis, keratinocytes (KC) 
were found to express ICAM-1 molecules and ICAM-1/LFA-1 
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and rh transforming growth factor beta (TGF/3) did not in-
crease ICAM-1 surface expression. In contrast, rhTNF/3 sig-
nificantly up-regulated ICAM-1 expression in a time- and 
dose-dependent manner. Moreover, the combination of 
rhTNF/3 with rhiFNy increased the percentage ofiCAM-1-
positive KC synergistically. This stimulatory effect of 
rhTNF/3 was further confirmed by the demonstration that 
rhTNF/3 was capable of markedly enhancing ICAM-1 
mRNA expression in KC. Finally, exposure ofKC in vitro to 
sublethal doses ofUV radiation (0-100 J/m2) prior to cyto-
kine {rhiFNr, rhTNFa, rhTNF/3) stimulation inhibited 
ICAM-1 up-regulation in a dose-dependent fashion. These 
studies identify TNF/3 and UV light as potent regulators of 
KC ICAM-1 expression, which may influence both attach-
ment and detachment of leukocytes and possibly viruses to 
KC.J Invest Dermato/95:127-131 1990 
binding appears to be the major pathway by which lymphocytes 
and/or monocytes are able to attach to KC [4). In addition, ICAM-1 
may also be involved in viral infection, because a major human 
picorna virus receptor recently has been demonstrated to be identi-
cal to ICAM-1 (5,6]. 
ICAM-1 is a glycosylated membrane protein with a molecular 
weight ranging from 90-114 kD (7). Normal human KC express 
no or only small numbers of ICAM-1 molecules, but stimulation 
with inflammatory cytokines such as interferon gamma (IFNy) and 
tumor necrosis factor alpha (TNFa) may increase ICAM-1 up to 
1.8 X 106 sites/keratinocyte [4]. Accordingly, KC expressing 
ICAM-1 can easily be detected in biopsies taken from skin lesions in 
psoriasis, allergic contact dermatitis, and atopic dermatitis, whereas 
no ICAM-1 is found on KC from normal skin [8,9). This may be 
caused by cytokines released from KC as well as T lymphocytes and 
monocytes [10). 
In order to further define the regulatory mechanisms of KC 
ICAM-1 expression, in the present study, a variety of cytokines 
different from IFNy and TNFa were tested for their effects on 
ICAM-1 expression on transformed or normal human KC. In addi-
tion, the effect of in vitro ultraviolet radiation (UV) on the constitu-
tive and cytokine-induced KC ICAM-1 expression was assessed. 
MATERIALS AND METHODS 
Cytokines and Antibodies Recombinant human (rh) interleu-
kin (IL) la, rhiL-4, rhiL-5, rhiL-6, rh-granulocytejmacrophage 
colony-stimulating factor (GM-CSF), and rhiFN-r were purchased 
from Genzyme Corp., Boston, MA. Recombinant human TNFa, 
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rh-tumor necrosis factor beta (TNFft) , and interferon alpha (IFNa) 
were a friendly gift from Dr. G.R. Adolf, Ernst-Boehringer-lnsti-
tute, Vienna, Austria. Highly purified porcine transforming growth 
factor beta (TGFft) was obtained from R+D Systems Inc., Minneap-
olis, MN. Monoclonal antibody (MoAb) 84H10 (anti-ICAM-1, 
mouse IgG 1) was purchased from Immunotech, Marseille, France. 
A mouse IgG1 isotype control antibody was obtained from Sigma 
Chemicals (St. Louis, MO) and the FITC-conjugated affinity-puri-
fied goat anti-mouse Fab2 from Dianova, Hamburg, FRG. 
Cell Culture The human carcinoma cell line KB (ATCC, Rock-
ville, MD) was maintained in monolayer cultu~es at 37oC in a 
humidified atmosphere containing S% C02 as previously described 
[11}. For cytokine stimulation, cells were plated at a density of 
5 X 105/ ml in six-well tissue-culture plates {Costar, Uppsala, Swe-
den) in the presence or absence of the indicated cytokine(s). For 
assessment of ICAM-1 surface expression, KC were collected at the 
indicated time points by treatment with cold PBS and the subse-
quent use of a rubber policeman. In some experiments, long-term 
cultured normal human foreskin KC (HNK) were used, which had 
been obtained from Clonetics Corporation, San Diego, CA and 
maintained in a defined keratinocyte growth medium (Clonetics, 
San Diego, CA) [12}. 
Immunofluorescence Flow Cytometry Collected and 
washed cells (1 X 106) were incubated with a 1:40 dilution of MAb 
84H10 or the equivalent amount of a mouse IgG1 isotype control 
antibody for 30 min at 4 o C, washed 3 times in PBS containing 
0.05% sodium azide, resuspended, and incubated with a 1:20 dilu-
tion of goat anti-mouse FITC-(Fab')2 for 30 min at 4°C. Subse-
quently, cells w ere washed 3 times and either analyzed immediately 
or fixed with 1% paraformaldehyde and analyzed within 4 d. FACS 
analysis was performed using a FAeS SCAN (Becton Dickinson, 
Mountain View, eA) . Prior to analysis, cells were routinely stained 
with propidium iodine to exclude dead cells and usually 5000 cells 
per sample were assessed . Data are given either as histograms of 
fluorescence intensity versus cell number or as% IeAM-1 reactive 
cells in comparison to unstimulated control cells. 
Ultraviolet Radiation Human epidermoid carcinoma cell line 
(KB) cells were exposed in vitro to UV radiation either before or 
after cytokine stimulation. 1 X 106 cells were placed in 35 X 10 
mm culture dish es (Falcon, O xnard, CA) in H ank's balanced salt 
solution without phenol red (Gibco, Paisley , Scotland) and then 
exposed to various doses of UV radiation from a bank of 4 FS 20 
sunlamps (Westinghouse Electncal Corp., Bloomfield, NJ) that are 
known to emit primarily in the UVB range (280-320 nm) . The 
UVB output was monitored by means of an IL 700 research radio-
meter and SEE 240 UVB photodetector (International Light, N ew-
buryport, MA) and was approximately 24 X 1 0~5 W / cm2 at a tube-
to-target distance of 22 em. In order to obtam a homogenously 
irradiated cell population, culture dishes wer~ gently shaken every 
15 seconds during UV exposure. After IrradiatiOn, cells were col-
lected, washed, and then analyzed for IeAM-1 expression either 
immediately or after a 24-h incubation period. Viabili.ty o.f irra-
diated cells, as assessed by trypan blue exclus1on or prop1dmm 10dme 
staining was > 90% for the entire duration of the culture period. 
Northern Blot Analysis Northern blot analysis was performed 
as previously described [11}. Briefly, cultured KB cells were gently 
detached and subsequently lysed in 4 M guanidine isothiocianate. 
RNA was pell eted by ultracentrifugation through cesium chloride. 
The concentration of RNA was determined from A260 nm, and 
A260/A280 ratios were > 1.7. RNA was electrophoresed in 1.2% 
agarose gels containing formaldehyde {2.2 M). After capillary 
transfer of the RNA to nitrocellulose (Schleicher & Schuell , Dasse l, 
FRG) membranes were prehybridized for at least 4 h by using a 
hybridizing solution containing 10% dextrane sulfate, 40% forma-
mide, 20% 20 X sse, salmon sperm DNA (50 ,ug/ml), and yeast 
transfer RNA (50 ,ug/ml). ICAM-1 mRNA was detected by using a 
3.0-kb eDNA probe, which was a kind gift from Dr. T .A. Springer, 
Dana Farber Cancer Institute, Harvard Medical School, Boston, 
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MA. IeAM-1 eDNA or mouse fi-actin eDNA, which was obtain , 
from Dr. P. Nielson, Max-Planck-lnstitut fur Immunbiolog~ 
Freib~rg, FRG, were labeled by nick translation with [a32-p]deo~ 
yadenme tnphosphate (Amersham, Buchlar, FRG) and Northe~ 
blot analys1s was performed usmg 10 ,ug of total RNA under stril\ 
gent washing conditions (three times for 20 min by using 0 .1 \ 
SSe and 0.1% SDS at 65 °C). Blots were exposed to an x-ray film ~ 
-70oe for 24 h. 'I 
Statistical Analysis Statistical significance of the data was calc14 lated using Student t test. ' 
RESULTS 
In initial experiments, various cytokines, which are known to b 
produced by Ke andjor leukocytes, were examined for the ·~ 
IeAM-1 enhancing activity on HNK or KB cel ls using FAeS anaj~ 
ysis. IeAM-1 expression could be up-regulated by IFNy and to \ 
lesser but signi~cant extent by TN Fa a.fter a 24-h incubation perio~ 
(Table I) . No mductlon could be ach1eved when cells were incu 
bated with rhiL-1a, rhiL-4, rhiL-5, rhiL-6, rhGM-CSF, rhiFN \ 
or highly purified TGF,B. Although the experiments presented ~ 
Table I employed 10 U/ml ofiL-1a, IL-4, IL-6, IL-6, IFNa, Glv{1 
eSF, an~ 1 ,ugjml of TFGft, essentially identical results were o~ 
tamed With a wtde range of cytokine doses (0.1 - 1000 U /ml 0~ 
IL-1a, IL-4, IL-5; 0.1-10,000 U/ml of IL-6, GM-eSF, IFN ~ 
0.01 - 1000 ngjml ofTGFft; data not shown). Recombinant hum~ 
TNFft, however, significantly up-regulated IeAM-1 expression oll 
both t~ansformed and normal human KC (Table I; Fig 1). Maxirnar 
mduct1on of IeAM-1 surface expression could be observed upo~ 
stimulation with 5000 U TNFP/ml (Table II). The TNFP-rn ' 
diated increase in IeAM-1 expression was not detectable after a 2~ 
incubation period, but became apparent after 6 h with a peak at 16 ~ 
(Ftg 2). Because ICAM-1 induction required relatively high dose'\ 
ofTNFft, it was next investigated whether lower, more physiologi~ 
amounts of TNFP would be capable of inducing ICAM-1 in th ~ 
presence o~ IFNr. Accordingly, the combined addition of TNF~ 
and IFNr mcreased the percentage of IeAM-1 reactive KB cell 
gr':!ater tba~ the sum ofieAM-1 positive cells after incubation wit~ 
each cytokme alone (Table II; Fig 1). This effect was most pr~ 
n?unced wl~e~ TNFftwas used in subopitmal doses, which by itsel~ 
d1d not exlubtt any IeAM-1 inducing activity. In contrast, nosy~ 
ergistic and even no additive effect could be observed, when R:.J\ 
Table I. Effect of Different eytokines on Keratinocyte 
ICAM-1 Expression• 
Stimulated With n' 
Medium 5 
IFNr (1000 U j ml) 5 
TN Fa (500 U j ml) 3 
TNFfJ (5000 U j ml) 5 
IL-1a (10 U / ml) 3 
IL-4 (10 Ujml) 3 
IL-5 (10 U jml) 3 
IL-6 (10 Ujml) 3 
IFNa (10 U/ml) 3 
GM-CSF(10Ujml) 3 
TGFfJ (1 tlg/ml) 3 
Percentage ICAM-1-
positive KC 
KB HNIC 
4±3 3± 2 
56±4' 47± 7< 
31 ± 4 n.d.' 
27 ± 3' 25 ± 3t 
10 ± 5 n.d. 
5±3 n.d. 
3±2 n.d. 
6±4 n.d. 
8±2 n.d. 
4±2 n.d. 
5±3 n.d. 
'Transformed human kcratinocyres or normal , long-term cultured human keratino. 
cytes (HNK) were cultured for 24 h with the indicated cytokines. Percentage of 
!CAM-I - positi ve keratinocytes was assessed cytofluorornetrically using MoAb 84H IO 
as described in Maceria[S<md Meclwds. Data are givett as mean± SD o£3- 5 experirnen~ 
as indicated. 
bn, number of experiments. l > 0.001 compared with medium. 
n.d. , not done. 
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Figure 1. FACS analysis of rhTNFP- and rhiFNy-induced ICAM-1 -
positive keratinocytes. Transformed human keratinocytes were incubated 
for 24 h without stimulus, with rhTNFP (5000 U/ ml) , rhiFNy (1000 
U /ml), or rh TNFPplus rh IFNy. The percentage ofiCAM-1- positive cells 
was determined cytofluorometrically using MoAb 84H10 as described ir. 
Materials at1d Methods. Data are given as histograms of fluorescence intensity 
versus cell number. The first dotted li11e from the left represents the cutoff for 
isotype control. The percentages of ICAM-1-positive cells were 7% 
unstimulated, 29% TNFP, 55% IFNy, 96% TNFP + IFN-r. 
cells were stimulated with rhTNF,B in combination with rhTNFa, 
rhGM-CSF, rhiL-4, or rhiL-6 (data not shown). 
To determine whether rhTNF,B-induced ICAM-1 cell-surface 
expression was due to the novel synthesis of these molecules, 
Northern blot analysis was performed. RNA extracted from KB 
cells was hybridized with a radiolabeled eDNA probe encoding for 
Table II. Synergistic Induction ofiCAM-1 on KC by IFNy 
and TNF,B• 
IFNy (Ujml) 
0 
1000 
0 
4±3 
56± 8' 
Percent ICAM-1-positive KC 
rhTNFp (U/ ml) 
50 500 
8±4 
79 ±9' 
12 ± 3b 
90± 8' 
5000 
33 ± 1' 
92±7' 
'Transformed human keratinocytes were cultured for 24 h with rhJFNy (1000) 
U /ml) and various concentrations of rhTNFP (0, 50, 500, and 5000 U / ml). Percentage 
of ICAM-1- positive keratinocytes was assessed cytofluorometrically using MoAb 
84H10 as described in Materials and Methods (mean ± SD of three experiments). 
'p > 0.05 as compared with unstimulated cells. 
'p > 0.001 compared with unstimulated cells. 
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Figure 2. Time dependence of TNFP-induced keratinocyte ICAM-1 ex-
pression. Transformed human keratinocytes were stimulated with rhTNFP 
(5000 U/ ml) for various periods of time (0, 2, 6, 8, 16, .24, 48 h) and then 
analyzed for ICAM-1 expression cytofluorometrically using MoAb 84H1 0. 
Data of three experiments arc given as percentage oflCAM-1- positive cells 
as compared to control cells. ••, p > 0.002 as compared to cells at 0 h; ••• , 
p > 0.001 as compared to cells at 0 h . 
ICAM-1. Unstimulated KB cells expressed clearly detectable but 
low amounts of ICAM-1 -specific mRNA (Fig 3, lane 1). Stimula-
tion of cells for 4 h with either rhiFN-r or rhTNF,B strongly en-
hanced ICAM-1 mRNA expression (Fig 3, lanes 2 and 3). Moreover, 
the combination of both cytokines induced ICAM-1 mRNA ex-
pression stronger than each cytokine alone (lane 4) . The differences 
in ICAM-1 mRNA expression were not due to different amounts of 
total RNA, because hybridzation with a ,8-actin probe gave almost 
identical signals in all four lanes . 
UV radiation is known to exhibit a variety of immunosuppressive 
1 3 4 
+- 285 
+-185 
B-actin 
Figure 3. North em blot analysis for the expression of ICAM- 1 mRNA in 
transformed human keratinocytc cells. Transformed human keratinocytcs 
were incubated for 4 h without stimulus (latle 1), in the presence of rhiFNy 
(1000 Ujml, latte 2), rhTNFP (5000 U/ml, lat1e 3), or a combination of 
rhTNFP (5000 U/ ml) and rhiFNy (1000 U/ml) (laue 4). N orthern blot 
analysis of total cellular RNA (10 ,ug) used a 32P-Iabeled ICAM-1 eDNA 
probe or a P-actin probe as a control. 
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activities including the inhibition of IFNy-induced cell-surface 
receptor expression on epidermal cells [13-15]. In order to assess 
the effect of UV irradiation on cyt?kii~e-induced ICAM-1 expres-
sion on KC, KB cells were exposed 111 vitro to sublethal doses ofUV 
light before treatment with optimal concentrations ofiFNy. Expo-
sure of cells to doses ofUV radiation up to 100 J/m2 UV decreased 
ICAM-1 surface expression in a dose-dependent fashion (Table III). 
This inhibitory effect ofUV light could also be observed when K.C 
were stimulated with TNFa or TNF/3 instead of IFNy. In contrast, 
UV irradiation did not effect the low constitutive ICAM-1 expres-
sion of unstimulated KB cells within the 24-h incubation period or 
the cytokine-induced ICAM-1 expression of cells that had first been 
stimulated for 24 h with IFNy and then exposed to UV radiation 
(data not shown). 
DISCUSSION 
These studies provide clear evidence that stimulation of human KC 
with rhTNF/3 markedly up-regulates ICAM-1 cell-surface expres-
sion. This is in agreement with recent reports showing that TNF/3 is 
capable of up-regulating ICAM-1 molecules on !mman fetal ast:o-
cytes and endothelial cells [16?17]. TNF/3-med1ated ICA~-1 111-
duction was weaker than IFNy-mduced ICAM-1 up-regulatiOn, but 
resembled that achieved with TN Fa, indicating that both cytokines 
may act via a similar mechanism. This is further supported by the 
observation that addition of optimal doses of both cytokines to K.C 
cultures failed to increase the percentage of ICAM-1- positive cells 
above the level that could be observed after stimulation with each 
cytokine alone. Accordingly, human TNFa and TNF/3 show 28% 
structural homology, the genes for both cytokines are closely 
linked, and TNFa and TNF/3 may compete for the same receptor 
[ 18, 19]. In contrast to these similarities, several important differ-
ences between these two cytokines have been reported. TNF/3 is a 
T-cell derived cytokine, which is not produced by normal mono-
cytes [20] . TNFa, however, is secreted by cells of monocyte/mac-
rophage lineage and as recently demonstrated by keratinocytes 
[10,21,22]. In addition to different cellular sources, TNFa and 
TNF/3 also .differ in their biologic activities. For example, TNFa, 
but not TNF/3, does induce production of a hematopoietic growth 
factor from human endothelial cells [23) . In the present study, both 
cytokines were found to be capable of inducing equivalent numbers 
ofiCAM-1-positive KC, but only ifTNFjJwas used in concentra-
tions that were about tenfold higher than those used for TNFa. 
Similarly, TNF/3 was found to be less active than TNFa in stimula-
tion of endothelial cell adhesiveness for neutrophils [23). Low doses 
ofTNF/3, however, potently increased ICAM-1 surface expression 
if combined with IFNy. A similar synergism between TNF/3 and 
IFNy previously had been observed for class II antigen or IgG Fe 
receptor induction on a variety of human cell types [24-26). Be-
cause IFNy has been shown to up-regulate cell-surface receptors for 
Table III. In Vitro UVB-Irradiation Inhibits Cytokine-Induced 
ICAM-1 on Human K.eratinocytes" 
rhiFNy 
rhTNFa 
rhTNFjJ 
Percentage ofJCAM-1-positive KC 
0 
53± 9 
30±2 
30± 6 
UV O/m2) 
so 
13 ± 26 
n.d.' 
n.d. 
100 
6±3' 
6±2' 
2± 1' 
'Transformed human keratinocytes were exposed in vitro to various doses of UV 
radiation (0-100 J/ m2) and subsequently incubated for 24 h with either rhiFNy (1000 
U/ml), rhTNFa (500 U/ml), or rhTNFp (5000 U/ml). Percentage of ICAM-1-
positive cells was determined by FACS analysis using MoAb 84H10 as described in 
Materials and Methods (mean ± SE of three expenmenrs). UVB radiation did not alter 
JCAM-1 expression on unstimulated KB cells after the 24-h incubation period. 
'p > 0.002 as compared to unirradiated cells. 1 > 0.001 as compared to unirradiated cells. 
n.d., not done. 
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TNFajTNF/3, this may at least partially account for the synergistic 
induction ofiCAM-1 molecules on human KC by these two cyto-
kines (19,27}. Accordingly, TNFa previously had been reported to 
synergize with IFNy in inducing keratinocyte ICAM-1 expression 
(4). These data clearly indicate that two closely related cytokines, 
TNFa and TNF/3, differentially affect a common target cell, the 
human KC. 
The increase ofiCAM-1 expression on human KC upon stimula-
tion with TNFjJmay be explained by the induction of biosynthesis 
ofiCAM-1 molecules or by the enhanced cell-surface expression of 
preformed intracellularly localized ICAM-1 molecules as has been 
reported for human peripheral blood monocytes [28). In the present 
study, an increase in ICAM-1 reactive KC could not be observed 
after a 2-h stimulation of KB cells with TNF/3 but was clearly 
detectable after 6 h. Moreover, stimulation of cells for 4 h with 
TNF/3 markedly enhanced ICAM-1 mRNA expression. Because 
the kinetics of TNF/3-induced ICAM-1 gene transcription are evi-
dently well in line with the immunofluorescence data, it is proposed 
that TNF/3-induced KC ICAM-1 expression is primarily due to de 
novo synthesis of ICAM-1 molecules. In contrast to IFNy, TNFa: 
and TNFjJ, all other cytokines tested failed to significantly induce 
ICAM-1 surface expression. These negative data, however, have 
been derived from experiments employing malignant epidermal 
cell lines and therefore it can not be excluded that some of these 
factors may be able to modulate ICAM-1 expression on normal, 
untransformed keratinocytes. 
Ultraviolet radiation is a potent modulator of cell-mediated im-
mune responses and this UV -induced immunosuppression may 
contribute at least in part to alterations of epidermal cell cytokine 
production and cell-surface antigen expression (13). The experi-
ments reported have demonstrated that in vitro irradiation of trans-
formed human KC with sublethal doses of UV dose-dependently 
inhibited IFNy, TNFa and TNF/3 induced ICAM-1 expression. In 
contrast, exposure of cells to UV radiation after cytokine stimula-
tion did not affect ICAM-1 expression. Similarly, it was recently 
reported that IFNy-induced ICAM-1 up-regulation on HNK may 
be inhibited by in vitro UV exposure (29]. Moreover, UV radiation 
has also been shown to inhibit IFNy-induced HLA-DR antigen 
expression on KC, but only if cells were irradiated prior to cytokine 
stimulation [14]. Finally, experiments employing epidermal Lan-
gerhans cells and human peripheral blood monocytes have demon-
strated that UV radiation of cells did not down-regulate expression 
of surface molecules that were already induced on these cells 
[15,30). T aken together, these results further support the concept 
that constitutive expression of immunologically relevant cell-sur-
face receptors remains unaltered by UV radiation, whereas the abil-
ity of cells to increase the expression of these antigens following UV 
exposure is impaired [13]. 
The present observation that two T -cell- derived cytokines 
IFNy and TNF/3, were capable of up-regulating KC ICAM-1 ex-
pression and that the combination of both cytokines even had a 
synergistic effect, strongly suggests an important role forT cells in 
KC ICAM-1 regulation. Depending on the quantity and timing of 
IFNy and TNF/3 generation in situ, T cells may generate a dens~ 
matrix of ICAM-1 molecules within the epidermis, which in turn 
allows binding ofLFA-1located on T cells to ICAM-1 expressed on 
KC and thus the generation and/or maintenance of aT cell infil-
trate. Accordingly, skin biopsy specimens from areas of allergic 
contact dermatitis contained ICAM-1-positive KC, whereas no 
ICAM-1 was expressed on KC from normal skin [8,9). 
Moreover, in inflammatory dermatoses such as psoriasis or atopic 
dermatitis, KC also have been found to express increased levels of 
ICAM-1 (9]. Although UV radiation therapy has proved to be of 
some benefit in these disorders, the exact mechanism of the anti-in-
flammatory properties of this modality is presently unknown. In 
view of the recent observation that in vitro UV radiation is capable 
of suppressing KC ICAM-1 expression, which is induced by inflam-
matory cytokines, one may speculate that this newly recognized 
inhibitory effect of UV light may at least partially account for in 
therapeutic usefulness. 
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In summary, these studies identify TNFfi as a cytokine that in 
addition to IFNy and TNFa is capable of up-regulating synthesis 
and expression of ICAM-1 molecules on human KC. In contrast, 
UV light was found to be a potent down-regulator of cytokine-in-
duced ICAM-1 expression on the KC surface . Thus, cytokines and 
UV radiation represent important regulators of KC ICAM-1 ex-
pression and may influence both attachment and detachment of 
leukocytes and possibly viruses to epidermal KC. 
The authors tha11k Christine Scholz for tee/mica/ assistatJCe atJd Monika Bednar for 
ca reful preparation of the ma11uscript. 
REFERENCES 
1. Springer T A, Dustin ML, Kishimoto TK, Marlin SD: The lymphocyte 
function-associated LFA-1, CD2, and LfA-3 molecules: cell adhe-
sion receptors of the immune system. Annu Rev Immunol 5:223-
252, 1987 
2. Altmann DM, Hogg N, Towsdale J, Wilkinson D: Cotransfection of 
ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell 
function in mouse L cells. Nature 338:512-514, 1989 
3. Shaw S, Ginter Luce GE, Quinones R, Gress RE, Springer TA, Sanders 
ME: Two antigen-independent adhesion pathways used by human 
cytotoxic T -cell clones. Nature 323:262-264, 1986 
4. Dustin ML, Singer KH, Tuck DT, Springer TA: Adhesion ofT lym-
phoblasts to epidermal keratinocytes is regulated by interferon 
gamma and is mediated by intercellular adhesion molecule 1 
(ICAM-1).] Exp Med 167:1323-1340, 1988 
5. Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, Marlor CW, 
K.amarck ME, McClelland A: The major human rhinovirus receptor 
is ICAM-1. Cell 56:839-847, 1989 
6. Staunton DE, Mer Iuzzi VJ, Rothlein R, Barton R, Marlin SD, Springer 
TA: A cell adhesion molecule, ICAM-1, is the major surface recep-
tor for rhinoviruses. Cell 56:849-853, 1989 
7. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA: Pri-
mary structure of ICAM-1 demonstrates interaction berween mem-
bers of the immunoglobulin and intcgrin supergene families. Cell 
52:925-933, 1988 
8. Vej lsgaard GS, Ralfkiaer E, Avnstorp C, Czajkowski M, Marlin SD, 
Rothlein R: Kinetics and characterization of intercellular adhesion 
molecule-1 (ICAM-1) expression on keratinocytes in various in-
flammatory skin lesions and malignant cutaneous lymphomas. JAm 
Acad Dermatol 20:782-790, 1989 
9. Singer KH, Tuck DT, Samspon HA, Hall RP: Epidermal keratinocytes 
express the adhesion molecule intercellular adhesion molecule-1 in 
inflammatory dermatoses. J Invest Dermatol 92:746-750, 1989 
10. Luger TA, Schwarz T : Epidermal cel l derived cytokines. In: Bos J 
(ed.). Skin Immune System. CRC Press, Boca Raton, FL (in press) 
11. Kirnbauer R, KockA, Schwarz T, Urbanski A, KrutmannJ, Borth W, 
Damm D, Shipley G, Ansel JC, Luger TA: IFN-,82, B cell differen-
tiation factor 2, or hybridoma growth factor (IL-6) is expressed and 
released by human epidermal cells and epidermoid carcinoma cell 
lines. J Immunol 142:1922 - 1928, 1989 
12. Boyce DS, Ham RG: Calcium regulated differentiation of normal 
human epidermal keratinocytes in chemically defined clonal culture 
and serum free serial culture. J Invest Dermatol81:335-405, 1983 
13. Krutmann J, Elmets CA: Recent studies on mechanisms in photoim-
munology. Yearly review. Photochem Photobiol 48:787-798, 
1988 
14. Khan IU, Ellner JJ, Elmets CA: Modulation of interferon-gamma-in-
duced keratinocyte HLA-DR expression by ultraviolet B radiation 
(abstr). J Invest Dermatol 92:458A, 1989 
MODULATION OF KERATINOCYTE ICAM-1 EXPRESSION 131 
15. Shimada S, Caughman SW, Sharrow SO, Stephany D, Katz SI: En-
hanced antigen-presenting capacity of cultured Langerhans cells is 
associated with markedly increased expression of Ia antigen. J Im-
munol 139:2551-2555, 1987 
16. Frohman EM, Frohman TC, Dustin ML, Vayuvegula B, Choi B, 
Gupta A, Van den Noort S, Gupta S: The induction of intercellular 
adhesion molecule 1 (ICAM-1) expression on human fetal astro-
cytes by interferon-gamma, tumor necrosis factor alpha, lympho-
toxin, and interleukin-1: relevance to intracerebral antigen presenta-
tion. J Neuroimmunol 23:117-124, 1989 
17. Pober JS, Lapierre LA, Stolpen AH, Brok TA, Springer TA, Fiers W, 
Bevilacqua MP, Mendrick DL, Gimbrone MA: Activation of cul-
tured human endothelial cells by recombinant lymphotoxin: com-
parison with tumor necrosis factor and interleukin 1 species. J lm-
munol138:3319-3324, 1987 
18. Paul NL, Ruddle NH: Lymphotoxin. Annu Rev Immunol 6:407-
438, 1988 
19. Aggarwal BB, Eessal u TE, H ass PE: Characterization of receptors for 
human tumor necrosis factor and their regulation by gamma-inter-
feron. Nature 318:665-667, 1985 
20. Sherry B, Cerami A: Cachectin/tumor necrosis factor exerts endo-
crine, paracrine, and autocrine control of inflammatoty responses. J 
Cell Biol1 07:1269-1277, 1988 
21. Kock A, Urbanski A, Luger TA: mRNA expression and release of 
tumor necrosis factor 0' by human epidermal cells (abstr).] Invest 
Dermatol 92:462A, 1989 
22. Koch F, Heufler C, Kaempgen E, Schneeweis D, Bock G, Schuler G: 
Tumor necrosis factor alpha maintains the viability of murine 
epidermal Langerhans cells in culture but in contrast to GM-CSF 
without inducing functional maturation. J Exp Med 171 :159 -171, 
1990 
23. Broudy VC, Harlan JM, Adamson JW: Disparate effects of tumor 
necrosis factor-a/cachectin and tumor necrosis factor-.8/lympho-
toxin on hematopoietic growth factor production and neutrophil 
adhesion molecule expression by cultured human endothelial cells. J 
Immunol 138:4298-4302, 1987 
24. Pujol-Borrell R, Todd I, Doshi M, Bottazzo GF, Sutton R, Gray D, 
Adolf GR, Feldmann M: HLA class II induction in human islet cells 
by interferon-gamma plus tumor necrosis factor or lymphotoxin. 
Nature 326:304-306, 1987 
25. Pfizenmaier K, Sheurich P, Schluter C, Kronke M: Tumor necrosis 
factor enhances HLA-A, B, C and HLA-DR gene expression in 
human tumor cell s. J Immunol 138:975-980, 1987 
26. Trinchieri G, Kobayashi M, Rosen M, Loudon R, Murphy M, Perussia 
B: Tumor necrosis factor and lymphotoxin induce differentiation of 
human myeloid cell lines in synergy with immune interferon. J Exp 
Med 164:1206-1255, 1986 
27. Tsujimoto M, Yip YK, Vilcek]: Interferon-gamma enhances expres-
sion of cellular receptors for tumor necrosis factor. J Immunol 
136:2441-2444, 1986 
28. Dougherty GJ, Murdoch S, Hogg N: The function of human intercel-
lular adhesion molecule-1 (ICAM-1) in the generation of an im-
mune response. Eur J Immunol 18:35-39, 1988 
29. Norris DA, Lyons MB, Rothlein R, Sawami M: An important new 
suppressive effect of ultraviolet light: inhibition of induction of 
adhesion molecules on human keratinocytes (abstr). J Invest Derma-
to! 92:493A, 1989 
30. KrutmannJ, Athar M, Mendel DB, Khan IU , Guyre PM, Mukhtar H, 
Elmets CA: Inhibition of the high affinity Fe receptor (FcyRI) on 
human monocytes by porphyrin photosensitization is highly spe-
cific and mediated by the generation of superoxide radicals. J Bioi 
Chem264:11407-11413, 1989 
